SEC Form 4 · accession 0001209191-17-060967
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis Clayton Cantley Jr.
Director
Period of report
Nov 13, 2017
Accepted (ET)
Nov 15, 2017 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Nov 13, 2017 | S | 1,000 | $62.07 | D | 82,394 | D | |
| Common stockF2,F3 | Nov 13, 2017 | S | 1,000 | $62.07 | D | 82,434 | I | See footnote |
| Common stockF4 | Nov 14, 2017 | S | 691 | $59.36 | D | 81,703 | D | |
| Common stockF4,F3 | Nov 14, 2017 | S | 691 | $59.36 | D | 81,743 | I | See footnote |
| Common stockF5 | Nov 14, 2017 | S | 309 | $60.46 | D | 81,394 | D | |
| Common stockF5,F3 | Nov 14, 2017 | S | 309 | $60.46 | D | 81,434 | I | See footnote |
| Common stockF6 | holding | — | — | — | 20,803 | I | See footnote | |
| Common stockF7 | holding | — | — | — | 20,803 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $61.87 to $62.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- F4The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.05 to $59.71. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.19 to $60.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
- F7Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.